Bill Gates on the Search for a Vaccine: Dr. Sanjay Gupta's coronavirus podcast for June 30

The Bill&Melinda Gates Foundation is contributing hundreds of millions of dollars toward Covid-19 vaccine trials. Bill Gates sits down with CNN Chief Medical Correspondent Dr. Sanjay Gupta and CNN's Anderson Cooper to discuss the prospect of developing a vaccine.
Source: - Health - Category: Consumer Health News Source Type: news

Related Links:

The funding for the coronavirus vaccine candidate being developed by Novavax comes as part of Operation Warp Speed.
Source: Health News: - Category: Consumer Health News Source Type: news
The Maryland-based company, which has never brought a product to market before, just made the biggest deal to date with the Trump administration ’s Operation Warp Speed.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Clinical Trials Vaccination and Immunization Coronavirus (2019-nCoV) Coalition for Epidemic Preparedness Innovations Novavax Inc AstraZeneca PLC Johnson & Moderna Inc Public-Private Sector Cooperation Trump, Donald Source Type: news
A Brazilian man infected with the AIDS virus has shown no sign of it for more than a year since he stopped HIV medicines after an intense experimental drug therapy aimed at purging hidden, dormant virus from his body, doctors reported Tuesday. The case needs independent verification and it’s way too soon to speculate about a possible cure, scientists cautioned. “These are exciting findings but they’re very preliminary,” said Dr. Monica Gandhi, an AIDS specialist at the University of California, San Francisco. “This has happened to one person, and one person only,” and it didn’t suc...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized HIV/AIDS News Desk wire Source Type: news
By Ambassador Lois M YoungNEW YORK, Jul 7 2020 (IPS) Our world is transfixed by the great human toll and economic impact of the worst global pandemic in a century. For the 65 million inhabitants of small island developing states (SIDS), the impact of the novel coronavirus (COVID-19) is reminiscent of the worst forms of extreme weather events that SIDS contend with annually. Such events cost lives, undermine our hard-earned development gains, and hamper the aspirations and quality of life of our people. Our governments are routinely compelled to shift already scarce resources from social and economic investments to recovery...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Climate Change Development & Aid Economy & Trade Financial Crisis Global Headlines Health Humanitarian Emergencies TerraViva United Nations Source Type: news
PLYMOUTH (CBS) – Massachusetts Gov. Charlie Baker said the state is expecting another summer with a high number of cases of Eastern Equine Encephalitis (EEE). Baker spoke about EEE preparations during a press conference Tuesday in Plymouth. “Every few years there are outbreaks with a higher number of cases,” said Baker. “We saw one of those just last summer. During the 2019 season, there were 12 human cases of EEE and six people died from those infections. It’s important to keep in mind that EEE outbreaks typically last two or three years. That means that we can expect the 2020 season to featu...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Eastern Equine Encephalitis EEE Gov. Charlie Baker Source Type: news
The contract represents a major bet on the Gaithersburg biotech ’s coronavirus work as the country hustles to find a viable vaccine to help end the pandemic.
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
CONCLUSION: We hope that this study could provide information on high risk groups for preemptive interventions. In the future, if a vaccine for COVID-19 is developed, it is expected that this study will be the basic data for recommending immunization by selecting those with chronic disease that had high risk of death, as recommended target diseases for vaccination. PMID: 32627443 [PubMed - in process]
Source: Journal of Korean Medical Science - Category: Biomedical Science Tags: J Korean Med Sci Source Type: research
Authors: Im JH, Nahm CH, Baek JH, Kwon HY, Lee JS Abstract Coronavirus disease 2019 (COVID-19) is rapidly spreading around the world, causing much morbidity and mortality everywhere. However, effective treatments or vaccines are still not available. Although convalescent plasma (CP) therapy can be useful in the treatment of COVID-19, it has not been widely used in Korea because of the concerns about adverse effects and the difficulty in matching patients to donors. The use of ABO-incompatible plasma is not contraindicated in treatment, but can be hesitated due to the lack of experience of physicians. Here, we descr...
Source: Journal of Korean Medical Science - Category: Biomedical Science Tags: J Korean Med Sci Source Type: research
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Company Gets $1.6 Billion From U.S. Government for Coronavirus Vaccine Vaccine maker Novavax will receive $1.6 billion from the U.S. government...
Source: - Daily MedNews - Category: General Medicine Source Type: news
GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago's recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK's pandemic adjuvant system. CoVLPs mimic the structure of the virus responsible for COVID-19 disease, allowing them to be recognised by the immune system.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured GlaxoSmithKline Business and Industry Source Type: news
More News: Coronavirus | COVID-19 | Health | Podcasts | Vaccines